Quantcast

Posts related to ‘GHDX’

biotech

Myriad Genetics, Angelina Jolie and Genomics in Focus

Myriad Genetics Inc. (NASDAQ: MYGN) is seeing a benefit in its share price after actress Angelina Jolie wrote that a genetic test using Myriad's gene sequencing tested positive for the ...
Read Full Story »

Thursday’s Big Stocks on the Move (CNQR, DUSA, GHDX, GNC, LOCK, MNST, PTN, QCOM, SGEN, TNK, WFM)

We have many stocks moving this morning. 24/7 Wall St. has tracked moves in shares of the following: Concur Technologies Inc. (NASDAQ: CNQR), DUSA Pharmaceuticals Inc. (NASDAQ: DUSA), Genomic Health Inc. ...
Read Full Story »

After-Hours Stocks on the Move (CNQR, GHDX, GNC, LOCK, MNST, QCOM, TNK, WFM)

We have many stocks moving in the after-hours trading session, and most of the moves are on earnings. 24/7 Wall St. has tracked moves in shares of the following: Concur ...
Read Full Story »

Top Analyst Upgrades and Downgrades (ADP, BK, BWLD, EXPD, GPS, GE, GHDX, LIFE, MYGN, NKE, NOK, NTRS, P, PAYX, RHT, QCOR, SQNM, STT, TIVO, TOT, WAG)

These are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday. Automatic Data Processing Inc. (NASDAQ: ADP) cut to Neutral at UBS. ...
Read Full Story »

Top Analyst Upgrades and Downgrades (ANF, AXP, BP, DDMG, GHDX, GNC, KYAK, KMI, MEOH, SPLS, THC)

These are the top analyst calls of upgrades, downgrades and initiations we have seen from Wall St. research calls this Thursday morning. Abercrombie & Fitch Co.(NYSE: ANF) cut to Underperform ...
Read Full Story »

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

We are now just about two weeks away from the king of biotech and pharma events in cancer treatments.  The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) ...
Read Full Story »

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

It is now getting close to the middle of May, and that means one thing for biotech investors.  The king of biotech and pharma events is about to take place.  ...
Read Full Story »

Top Analyst Upgrades & Downgrades (ADBE, EMR, HEV, FNSR, GHDX, KMI, KMP, KMR, MU, OC, SCHS, SBUX, SWC, TCT, TWGP)

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday morning. Adobe Systems Inc. (NASDAQ: ADBE) Maintained Neutral but cut estimates ...
Read Full Story »

The Month’s Biggest Index Losers: Chinese Agriculture, Genetic Analysis, and Agricultural Chemical And Fertilizer Stocks

There were strong losses in three Tickerspy indexes over the most recent 30-day period. This month's biggest losers are in Chinese agriculture, genetic analysis, and agricultural chemical and fertilizer stocks. Chinese agriculture stocks are down ...
Read Full Story »

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data presentations slated to start this weekend.   This is broken down ...
Read Full Story »

Previewing 2009 ASCO Abstracts (ABII, ALTH, ARQL, CLDX, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, OGXI, OSIP, PPHM, PFE, SNTA, ZIOP)

We are just about to get the first round of abstracts from companies presenting data at this year's American Society of Clinical Oncology meeting for 2009.  At BioHealthInvestor.com we compiled ...
Read Full Story »

Top 10 Pre-Market Analyst Calls (DVR, GHDX, KLAC, KR, LCAPA, LOW, NOK, PBT, TMA, UBS)

Below are the top calls that 247WallSt.com is focusing on in pre-market trading this Wednesday:Cal Dive International (NYSE: DVR) Raised To Overweight at JP Morgan.Genomic Health (NASDAQ: GHDX) Cut To ...
Read Full Story »